Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Bayesian group sequential design for a multiple arm randomized clinical trial

G L Rosner1, D A Berry

  • 1Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

Statistics in Medicine
|February 28, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Nitroprusside improves tumor perfusion during local 42°C hyperthermia.

Veterinary anaesthesia and analgesia·2017
Same author

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Breast cancer research and treatment·2016
Same author

Emerging innovations in clinical trial design.

Clinical pharmacology and therapeutics·2015
Same author

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.

The pharmacogenomics journal·2015
Same author

The Signature Program: Bringing the Protocol to the Patient.

Clinical pharmacology and therapeutics·2015
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This study introduces a novel Bayesian group sequential design for clinical trials comparing multiple treatments. It uses posterior probabilities to determine when to stop treatment accrual, enhancing trial efficiency and reducing false rejections.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Bayesian Inference

Background:

  • Group sequential designs enable interim analyses in randomized clinical trials.
  • Traditional designs often focus on two treatments and struggle with increased Type I error for multiple comparisons.
  • Bayesian methods offer a framework for sequential analysis using observed data.

Purpose of the Study:

  • To propose a Bayesian group sequential design for a four-treatment randomized clinical trial.
  • To utilize posterior probability calculations for adaptive stopping criteria.
  • To evaluate the frequentist properties of the proposed design via simulation.

Main Methods:

  • Development of a group sequential design incorporating Bayesian principles.
  • Application of posterior probability calculations to guide decisions on stopping treatment accrual.

Related Experiment Videos

  • Computer simulations to estimate frequentist characteristics like power under alternative hypotheses.

    • Main Results:

    • The proposed design effectively uses posterior probabilities for stopping rules in multi-treatment trials.
    • Simulations demonstrate the frequentist properties of the Bayesian-guided design.
    • The approach offers a practical method for designing efficient clinical trials.

    Conclusions:

    • Bayesian group sequential designs provide a robust framework for multi-treatment clinical trials.
    • Posterior probability calculations offer a straightforward method for adaptive trial management.
    • This design enhances efficiency and controls error rates in complex trial settings.